Copied
 
 
2022, DKK
21.12.2023
Bruttoresultat

788'

Primær drift

-3.459'

Årets resultat

-2.909'

Aktiver

6.064'

Kortfristede aktiver

1.398'

Egenkapital

-669'

Afkastningsgrad

-57 %

Soliditetsgrad

-11 %

Likviditetsgrad

50 %

Resultat
21.12.2023
Årsrapport
2022
21.12.2023
2021
22.12.2022
2020
02.12.2021
2019
30.10.2020
2018
11.12.2019
Nettoomsætning
Bruttoresultat788.4961.193.5051.622.729825.556273.215
Resultat af primær drift-3.459.346-3.309.497-1.103.46960.290198.315
Indtægter af kapitalandele (tilknyttede og associerede) 00000
Finansielle indtægter10410020
Finansieringsomkostninger00000
Andre finansielle omkostninger-262.078-170.746-105.561-2.108-648
Resultat før skat-3.721.414-3.480.202-1.209.03058.182197.687
Resultat-2.909.226-2.602.242-767.40541.158153.432
Forslag til udbytte00000
Aktiver
21.12.2023
Årsrapport
2022
21.12.2023
2021
22.12.2022
2020
02.12.2021
2019
30.10.2020
2018
11.12.2019
Kortfristede varebeholdninger00000
Kortfristede tilgodehavender fra salg og tjenesteydelser 1.323.8001.939.6701.377.806383.684698.345
Likvider74.613202.0931.262.987243.49716.654
Kortfristede aktiver1.398.4132.141.7632.640.793627.181714.999
Immaterielle aktiver og goodwill4.551.5765.017.3784.101.6871.536.197405.676
Finansielle anlægsaktiver60.45554.67137.4413.2808.830
Materielle aktiver53.780300.23538.00200
Langfristede aktiver4.665.8115.372.2844.177.1301.539.477414.506
Aktiver6.064.2247.514.0476.817.9232.166.6581.129.505
Aktiver
21.12.2023
Passiver
21.12.2023
Årsrapport
2022
21.12.2023
2021
22.12.2022
2020
02.12.2021
2019
30.10.2020
2018
11.12.2019
Forslag til udbytte00000
Egenkapital-669.2832.239.9432.757.185974.590633.432
Hensatte forpligtelser062.628727.787337.963162.058
Langfristet gæld til banker00000
Anden langfristet gæld00000
Leverandører af varer og tjenesteydelser647.938162.074174.076103.95456.337
Kortfristede forpligtelser2.789.1951.522.7081.274.825854.105334.015
Gældsforpligtelser6.733.5075.211.4763.332.951854.105334.015
Forpligtelser6.733.5075.211.4763.332.951854.105334.015
Passiver6.064.2247.514.0476.817.9232.166.6581.129.505
Passiver
21.12.2023
Nøgletal
21.12.2023
Årsrapport
2022
21.12.2023
2021
22.12.2022
2020
02.12.2021
2019
30.10.2020
2018
11.12.2019
Afkastningsgrad -57,0 %-44,0 %-16,2 %2,8 %17,6 %
Dækningsgrad Na.Na.Na.Na.Na.
Resultatgrad Na.Na.Na.Na.Na.
Varelagerets omsætningshastighed Na.Na.Na.Na.Na.
Egenkapitals-forretning 434,7 %-116,2 %-27,8 %4,2 %24,2 %
Payout-ratio Na.Na.Na.Na.Na.
Gældsdæknings-nøgletal Na.Na.Na.Na.Na.
Soliditestgrad -11,0 %29,8 %40,4 %45,0 %56,1 %
Likviditetsgrad 50,1 %140,7 %207,1 %73,4 %214,1 %
Resultat
21.12.2023
Gæld
21.12.2023
Årsrapport
21.12.2023
Nyeste:01.07.2022- 30.06.2023(offentliggjort: 21.12.2023)
Information om virksomhedens regnskabsklasse:GENERAL INFORMATIONThe financial statements of Techvolver ApS for the financial year 2021/22 have been prepared in conformity with the provisions of the Financial Statements Act on class B enterprises combined with a few rules on class C enterprises. The accounting policies applied in the financial statements are consistent with those of the previous year. The reporting currency is Danish kroner.
Oplysning om pantsætninger og sikkerhedsstillelser:7 Charges and securities As security for debt to Vækstfonden, the company has provided a corporate mortgage of DKK 3,500 thousand. The corporate mortgage comprises the following assets whose carrying amount at the balance sheet date is:Inventories 0 tDKKTrade receivables 115 tDKKOther plant, fixtures and operating equipement 54 tDKKConcessions, patens, etc. 4,552 tDKK
Beretning
21.12.2023
Dato for ledelsens godkendelse af årsrapporten:2023-12-08
Statement by Management on the annual report
Identifikation af den godkendte årsrapport:Today the Board of Directors and the Executive Board have discussed and approved the Annual Report of Techvolver ApS for the period 1. juli 2022 - 30. juni 2023.
Management's review
Beskrivelse af virksomhedens væsentligste aktiviteter:Main activities of the CompanyTechvolver ApS’s mission is to act in the cross section between humans and technology and to create accelerated technology adaptions by collaborating with key players in the life science industry. By engaging customers, technology partners and our capabilities we deployed in 2018 an automated pipette handling solution that eliminates EHS challenges and improve operational efficiency in laboratories.